Chronic indeterminate phase of Chagas' disease: Mitochondrial involvement in infection with two strains

Parasitology

Volumn 140, Issue 3, 2013, Pages 414-421

  Báez, Alejandra Lidia ^a   Lo Presti, María Silvina ^a   Fretes, Ricardo ^a   Díaz, Cintia ^a   Pons, Patricia ^a   Bazán, Paola Carolina ^a   Strauss, Mariana ^a   Rivarola, Héctor Walter ^a   Paglini Oliva, Patricia ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Chronic indeterminate Chagas' disease; mitochondria; myocardiopathy; respiratory chain; Trypanosoma cruzi strains

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ARTICLE; CELL FUNCTION; CELL STRUCTURE; CHAGAS DISEASE; CHRONIC DISEASE; CITRIC ACID CYCLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HEART DISEASE; HEART MITOCHONDRION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY CHAIN; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CHRONIC DISEASE; CITRATE (SI)-SYNTHASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; HEART; HOST-PARASITE INTERACTIONS; HUMANS; MALE; MICE; MITOCHONDRIA; MYOCARDIUM; PARASITEMIA; SPECIES SPECIFICITY; TRYPANOSOMA CRUZI;

EID: 84874179796     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182012001771     Document Type: Article

References (48)

1. Andrade, S. G., Campos, R. F., Sobral, S. C., Magahlanes, J. B., Guedes, R. S. P. and Guerreiro, M. L. (2006). Reinfections with Trypanosoma cruzi strains of different biodems as a factor of aggravation of miocarditis and myosites in mice. Revista da Sociedade Brasileira de Medicina Tropical 39, 1-8
2. Araujo Jorge, T. C., Waghabi, M. C., Soeiro, M. D. E., Keramidas, M., Bailly, S. and Feige, J. J. (2008). Pivotal role for TGF beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent chagasic myocardiopathy. Cytokine and Growth Factor Reviews 19, 405-413
3. Báez, A., Lo Presti, M. S., Rivarola, H.W., Guzman Mentesana, G., Pons, P., Fretes, R. and Paglini-Oliva, P. (2011). Mitochondrial involvement in the chronic chagasic cardiomiopathy. Transactions of the Royal Society of Tropical Medicine and Hygiene 105, 239-246
4. Báez, A., Lo Presti, S., Rivarola, W., Pons, P., Fretes, R. and Paglini-Oliva, P. (2008). Trypanosoma cruzi: Mitochondrial alterations produced by two different strain in the acute phase of the infection. Experimental Parasitology 120, 397-402
5. Bern, C., Montgomery, S. P., Herwaldt, B. L., Rassi, A., Jr., Marin-Neto, J. A., Dantas, R. O., Maguirre, J. H., Acquatella, H., Morillo, C., Kirchhoff, L. V., Gilman, R. H., Reyes, P. A., Salvatella, R. and Moore, A. C. (2007). Evaluation and treatment of Chagas disease in the United States: A systematic review. JAMA: The Journal of the American Medical Association 298, 2171-2181
6. Biolo, A., Ribeiro, A. L. and Clausell, N. (2010). Chagas cardiomyopathy-where do we stand after a hundred years? Progress in Cardiovascular Diseases 52, 300-316
7. Bradford, M. A. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-DNA binding. Analytical Biochemistry 72, 248-254
8. Bustamante, J. M., Rivarola, H.W., Fernández, A. R., Enders, J. E., Fretes, R. E. and Paglini Oliva, P. (2003). Indeterminate Chagas' disease: Trypanosoma cruzi strain and reinfection are factors involved in the progression of cardiopathy. Clinical Science 104, 415-420
9. Cardoni, M. I., Antunez, C., Morales, I. and Nantes, R. (1997). Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. The American Journal of Tropical Medicine and Hygiene 56, 329-334
10. Coura, J. R. (1988). Determinantes epidemiológicos da doenca do Chagas no Brasil:a infeccao da doenca e sua morbid-mortalidade. Memórias do Instituto Oswaldo Cruz 83, 392-402
11. Coura, J. R., Borges-Pereira, J. (2010). Chagas disease: 100 years after its discovery. A systemic review. Acta Tropica 115, 5-13
12. De Oliveira, T. B., Pedrosa, R. C. and Filho, D.W. (2007). Oxidative stress in chronic cardiopathy associated with Chagas disease. International Journal of Cardiology 116, 357-363
13. Dhiman, M., Nakayasu, E. S., Madaiah, Y. H., Reynolds, B. K. and Wen, J. J. (2008). Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: Implications in Chagas' disease. The American Journal of Pathology 173, 728-740
14. Dhiman, M., Zago, M. P., Nunez, S., Amoroso, A., Rementeria, H., Dousset, P., Nunez Burgos, F. and Garg, N. J. (2012). Cardiac-Oxidized Antigens Are Targets of Immune Recognition by Antibodies and Potential Molecular Determinants in Chagas Disease Pathogenesis. Plos ONE 7, 1-13
15. Elizari, M. B. (1999). Chagasic myocardiopathy. Historical prospective. Medicine 59, 25-40
16. Enders, J. E., Paglini, P., Fernández, A. R., Marco, F. and Palma, J. A. (1995). Cardiac beta-receptors in experimental Chagas' disease. Revista do Instituto de Medicina Tropical de Sao Paulo 37, 59-62
17. Garg, N., Popov, V. L. and Papaconstantinou, J. (2003). Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: Implication in chagasic myocarditis development. Biochimica et Biophysica Acta 1638, 106-120
18. Gea, S., Gruppi, A., Cerbán, F., Pistoresi-Palencia, M. C. and Vottero-Cima, E. (1992). Immune response in mice immunized with acidic antigenic fractions from Trypanosoma cruzi cytosol. Revista del Instituto de Medicina Tropical de Sao Paulo 34, 389-394
19. Gupta, S., Bhatia, V., Wen, J., Wu, Y., Huang, M. and Garg, N. (2009). Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes. Free Radical Biology & Medicine 47, 1414-1421
20. Gutierrez, F. R., Mineo, T.W., Pavanelli, W. R., Guedes, P. M. and Silva, J. S. (2009). The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Memórias do Instituto Oswaldo Cruz 104, 236-245
21. Jarreta, D., Orus, J., Barrientos, A., Miro, O., Roig, E., Heras, M., Moraes, C. T., Cardellach, F. and Casademont, J. (2000). Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovascular Research 45, 860-865
22. Labriola, C., Sousa, M. and Cazzulo, J. J. (1993). Purifcation of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi by affinity chromatography. Biological Research 26, 101-107
23. Long, X., Goldenthal, M. J., Wu, G. and Marín-García, J. (2004). Mitochondrial Ca2+ flux and respiratory enzyme activity decline are early events in cardiomyocyte response to H2O2. Journal of Molecular and Cellular Cardiology 37, 63-70
24. Lo Presti, M. S., Rivarola, H.W., Bustamante, J. M., Fernández, A. R., Enders, J. E., Levin, G., Juaneda, E., Fretes, R., Triquell, M. F. and Paglini-Oliva, P. A. (2008). Some components of the cardiac b-adrenergic system are altered in the chronic indeterminate form of experimental Trypanosoma cruzi infection. International Journal for Parasitology 38, 1481-1492
25. Macedo, V. (1999). Indeterminate form of Chagas disease. Memórias do Instituto Oswaldo Cruz 94, 311-316
26. Marin-García, J. and Goldenthal, M. J. (2008). Mitochondrial centrality in heart failure. Heart Failure Reviews 13, 137-150
27. Maya, J. D., Orellana, M., Ferreira, J., Kemmerling, U., Lopez Muñoz, R. and Morello, A. (2010). Chagas disease: Present status of pathogenic mechanisms and chemotherapy. Biological Research 43, 323331
28. Moncayo, A. and Silveira, A. C. (2009). Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Memórias do Instituto Oswaldo Cruz 104, 17-30
29. Pereira Silva, C., Del Carlo, C. H., Tavares de Oliveira, M., Jr., Scipioni, A., Strunz Cassaro, C. and Franchini Ramírez, J. A. (2009). Why do patients with chagasic cardiomyopathy have worse outcomes than those with non chagasic cardiomyopathy? Arquivos Brasileiros de Cardiology 91, 358-362
30. Polo-Romero, F. J., Beato-Pérez, J. L. and Romero-Portilla, C. (2011). Chagas: An emergent and unknown disease. Revista Clínica Española 211, 165-166
31. Prata, A. (2001). Clinical and epidemiological aspects of Chagas' disease. The Lancet Infectious Diseases 1, 92-100
32. Reesink, H.W. (2005). European strategies against the parasite transfusion risk. Transfusion Clinique et Biologique 12, 1-4
33. Ribeiro, A. L. and Rocha, M. O. (1998). Indeterminate form of Chagas disease: Considerations about diagnosis and prognosis. Revista da Sociedade Brasileira de Medicina Tropical 31, 301-314
34. Schummis, G. A. (2007). Epidemiology of Chagas Disease in non endemic countries: The role of international migration. Memórias do Instituto Oswaldo Cruz 102, 75-85
35. Storino, R. and Milei, J. (1994). Enfermedad de Chagas. Mosby, Doyma Argentina, Buenos Aires, Argentina, South America.
36. Talvani, A., Rocha, M. O., Barcelos, L. S., Gomes, Y. S., Ribeiro, A. L. and Teixeira, M. M. (2004). Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clinical Infectious Diseases 38, 943-950
37. Trounce, I. A., Kim, Y. L., Jun, A. S. and Wallace, D. C. (1996). Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell line. Methods in Enzymology 264, 484-509
38. Tsutsi, H. (2006). Oxidative stress in heart failure: The role of mitochondria. Internal Medicine 40, 1177-1182
39. Ueda, S., Masutani, H., Nakamura, H., Tanaka, T., Ueno, M. and Yodoi, J. (2002). Redox control of cell death. Antioxididants & Redox Signaling 4, 405-414
40. Umezawa, E., Stolf, A. M. S., Corbett, C. E. P. and Shikanai-Yasuda, M. A. (2000). Chagas' disease. Lancet 357, 797-799
41. Vyatkina, G., Bhatia, V., Gerstner, A., Papaconstantinou, J. and Garg, N. (2004). Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development. Biochimica et Biophysica Acta 1689, 162-173
42. Waghabi, M. C., De Souza, E. M., De Oliveira, J. M., Keramidas, M., Feige, J. J., Araujo Jorge, T. C., Bailly, S. (2009). Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas disease. Antimicrobial Agents and Chemotherapy 53, 4694-4701
43. Wen, J. J. and Garg, N. (2004). Oxidative modifications of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection. Free Radical Biology & Medicine 37, 2072-2081
44. Wen, J. J. and Garg, N. J. (2008). Mitochondrial generation of reactive oxygen species is enhanced at the Q(o) site of the complex III in the myocardium of Trypanosoma cruzi-infected mice: Beneficial effects of an antioxidant. Journal of Bioenergetics and Biomembranes 40, 587-598
45. Wen, J. J., Vyatkina, G. and Garg, N. (2004). Oxidative damage during chagasic cardiomyopathy development: Role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radical Biology &. Medicine 37, 1821-1833
46. Wen, J. J., Yachelini, P. C., Sembaj, A., Manzur, R. E. and Garg, N. (2006). Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Radical Biology & Medicine 41, 270-276
47. World Health Organization (2007). Report on Chagas Disease. World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland
48. Zingales, B., Andrade, S. G., Briones, M. R. S., Campell, D. A., Chiari, E. and Fernandez, O. (2009). A new consensus of Trypanosoma cruzi intraspecific nomenclature: Second revision meeting recommends TcI To TcVI. Memórias do Instituto. Oswaldo Cruz 104, 1051-1054